In each group, seven patients underwent prophylactic mastectomy because of a BRCA1 or BRCA2 gene mutation, while four patients underwent mastectomy following a diagnosis of invasive breast cancer. The gene discussed is BRCA2; the disease is invasive breast carcinoma.